BJP central leaders back Yediyurappa: BSY regime will be stable, says Amit Shah

Mangaluru, May 15: In a shocking development, five residents of Udupi district, who recently came from United Arab Emirates today tested positive for covid-19.

As many as 49 passengers among over 175 repatriates who were brought from Dubai to Mangaluru International Airport on May 12 were from Udupi district.

Hence they were quarantined in Udupi district and their throat swabs were sent for testing on the same day. Today, five of them obtained positive report. They were today shifted to TMA Pai covid-hospital from their hotel rooms.

Bengaluru, Jul 8: Karnataka has drafted 1,246 government employees into the crucial task of contact tracing to fight the coronavirus pandemic, and they have been warned of action if they refuse to work.

These are Group A, B and C employees from various departments who have been asked to report to senior IAS officer V Manjula, who heads a task force on Covid-19 contact tracing.

In an order, Chief Secretary TM Vijay Bhaskar on Tuesday said additional human resources were required to strengthen contact tracing, which is “a very important part” of controlling the spread of Covid-19.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.